Anticonvulsant hypersensitivity syndrome: A review

Expert Opinion on Drug Safety

Volumn 4, Issue 3, 2005, Pages 571-581

  Gogtay, Nithya J ^a   Bavdekar, Sandeep B ^a   Kshirsagar, Nilima A ^a  

^a KEM HOSPITAL   (India)

Author keywords

Anticonvulsant hypersensitivity syndrome (AHS); Aromatic anticonvulsant; Lymphocyte toxicity assay (LTA)

Indexed keywords

ALLOPURINOL; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIPYRETIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DIAZEPAM; DIPHENHYDRAMINE; DRUG METABOLITE; EPOXIDE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDANTOIN; HYDROXYZINE; IMMUNOGLOBULIN; LAMOTRIGINE; METHYLPREDNISOLONE; MINOCYCLINE; NORMEPHENYTOIN; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; PRIMIDONE; SORBINIL; SULFONAMIDE; TERBINAFINE; VALPROIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ALOPECIA; ANEMIA; ANOREXIA; ANTIBODY PRODUCTION; ANTICONVULSANT HYPERSENSITIVITY SYNDROME; APLASTIC ANEMIA; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; BIOACCUMULATION; BLINDNESS; BLOOD CLOTTING DISORDER; BONE MARROW DISEASE; BONE MARROW HYPOPLASIA; BRONCHIOLITIS OBLITERANS; CARDIOTOXICITY; CARDITIS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COLITIS; CONGESTIVE HEART FAILURE; CORNEA ULCER; COUGHING; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG COST; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; DYSPHAGIA; EARLY DIAGNOSIS; ENZYME DEFECT; EOSINOPHILIA; EPILEPSY; EPILEPTIC STATE; ERYTHEMA; ERYTHEMA MULTIFORME; ERYTHROCYTE SEDIMENTATION RATE; EYELID EDEMA; FACE EDEMA; FATIGUE; FEVER; FLU LIKE SYNDROME; GRAFT VERSUS HOST REACTION; GRANULOMATOUS HEPATITIS; GRANULOMATOUS VASCULITIS; HEADACHE; HEMATURIA; HEMOLYTIC ANEMIA; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPERPIGMENTATION; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE DEFICIENCY; IN VITRO STUDY; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; INFLAMMATION; INTERSTITIAL NEPHRITIS; JAUNDICE; KERATOCONJUNCTIVITIS SICCA; LABORATORY DIAGNOSIS; LEUKOCYTOSIS; LEUKOPENIA; LIVER DYSFUNCTION; LIVER NECROSIS; LIVER TOXICITY; LUNG TOXICITY; LYMPHADENOPATHY; LYMPHOCYTOSIS; LYMPHOCYTOTOXICITY; LYMPHOMA; MALAISE; MANDATORY REPORTING; MORBIDITY; MYALGIA; MYOCARDITIS; MYOPATHY; MYOSITIS; NECROTIZING ARTERITIS; NEPHROTOXICITY; OLIGURIA; PANCREATITIS; PANCYTOPENIA; PAPULE; PATHOGENESIS; PATIENT CARE; PATIENT COUNSELING; PERICARDITIS; PHARYNGITIS; PLASMAPHERESIS; PNEUMONIA; PRURITUS; PUSTULE; RESPIRATORY FAILURE; REVIEW; RHABDOMYOLYSIS; SCAR FORMATION; SEPSIS; SKIN DEFECT; SKIN EXFOLIATION; SPLENOMEGALY; STEVENS JOHNSON SYNDROME; SYMBLEPHARON; TERATOGENICITY; THYROID DISEASE; THYROIDITIS; TONSILLITIS; TOXIC EPIDERMAL NECROLYSIS; TOXIC HEPATITIS; UREA NITROGEN BLOOD LEVEL; UVEITIS; VIRUS INFECTION; VOMITING;

ANTICONVULSANTS; DRUG HYPERSENSITIVITY; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; SYNDROME; TIME FACTORS;

EID: 19444381777     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.3.571     Document Type: Review

References (59)

1. BESSMERTNY O, HATTON RC, GONZALEZ-PERALTA RP: Andepileptic hypersensitivity syndrome in children. Ann. Pharmacother. (2001) 35(5):533-538.
2. KNOWLES SR, SHAPIRO LE, SHEAR NH: Anticonvulsant Hypersensitivity Syndrome. Incidence, Prevention and Management. Drug Saf. (1999) 21(6):489-501.
3. VITTORIO CC, MUGLIA JJ: Anticonvulsant hypersensitivity syndrome. Arch. Intern. Med. (1995) 155(21):2285-2290
4. GILMAN JT, DUCHOWNY M: Introduction: Allergic Hypersensitivity to Antiepileptic Drugs: Past, Present, and Future. Epilepsia (1998) 39(Supp 7):S1-S2.
5. TENNIS P, STERN R: Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology (1997) 49(2):542-546.
6. ROUJEAU JC, STERN R: Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. (1994) 331(19):1272-1285
7. SPIELBERG S, SHEAR N, HUTSON N et al.: In-vitro assessment of hypersensitivity syndrome associated with sorbinil. Ann. Intern. Med. (1991) 114(9):701-724.
8. KNOWLES S, SHAPIRO L, SHEAR N: Serious adverse reactions induced by minocycline: a report of 13 patients and review of the literature. Arch. Dermatol. (1996) 132(8):934-939.
9. GUPTA AK, KOPSTEIN JB, SHEAR NH: Hypersensitivity reaction to terbinafine. J. Am. Acad. Dermatol. (1997) 36(6 Pt 1):1018-1019
10. KNOWLES SR, GUPTA AK, SHEAR NH, SAUDER D: Azathioprine hypersensitivity-like reactions- a case report and review of the literature. Clin. Exp. Dermatol. (1995) 20(4):353-356.
11. MULLICK F, ISHAK F: Hepatic injury associated with diphenyl hydantoin therapy. Am. J. Clin. Pathol. (1980) 74(4)442-452.
12. AGUIR D, PAZO R, DURAN I et al.: Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J. Neurooncol. (2004) 66(3):345-350
13. ROUJEAU J-C, CHOSIDOW O, SAIAG P, GUILLAUME J-C: Toxic epidermal necrolysis (Lyell Syndrome). J. Am. Acad. Dermatol. (1990) 23(6 pt 1):1039-1058.
14. DREIFUSS FE, LANGER DH: Hepatic considerations in the use of antiepileptic drugs. Epilepsia (1987) 28(Supp2):S23-S29.
15. SILVERMAN AK, FAIRLEY J, WONG RC: Cutaneous and immunologic reactions to phenytoin. J. Am. Acad. Dermatol. (1988) 18(4 Part 1):721-741.
16. SPIELBERG S: In-vitro analysis of idiosyncratic drug reactions. Clin. Biochem. (1986) 19(2):142-144.
17. GLEICHMANN H: Studies on the mechanism of drug sensitization: T cell dependent popliteal lymph node reaction to diphynylhydantoin. Clin. Immunol. Immunopathol. (1981) 18(2):203-211.
18. KANO Y, INAOKA M, SHIOHARA T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol. (2004) 140(2):183-188.
19. SHEAR N, SPIELBERG S: Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk. J. Clin. Invest. (1988) 82(6):1826-1832.
20. SPIELBERG S, GORDON G, BLAKE D, MELLITS ED, BROSS DS: Anticonvulsant toxicity in vitro: Possible role of arene oxides. J. Pharmacol. Exp. Ther. (1981) 217(2):386-289.
21. RILEY F, LEEDER S: In vitro analysis of metabolic predisposition to drug hypersensitivity reactions. Clin. Exp. Immunol. (1995) 99(1):1-6.
22. SPIELBERG S, GORDON G, BLAKE D, GOLDSTEIN DA, HERLONG HF: Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med. (1981) 305(13):722-727.
23. FRIEDMANN P, STRICKLAND I, PIRMOHAMED M, PARK BK: Investigations of mechanisms in toxic epidermal necrolysis by carbamazepine. Arch. Dermatol. (1994) 130(5):596-604.
24. LEEDER J, RILEY R, COOK V, SHELBERG SP: Human anti-cytorchrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J. Pharmacol. Exp. Ther. (1992) 263(1):360-367.
25. MARTZ F, FEILINGER C, BLAKE DA: Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolites in gestational tissue. J. Pharmacol. Exp. Ther. (1977) 203(1):231-239.
26. BENET LZ, MITCHELL JR, SHEINER LB: Pharmacokinetics: The dynamics of drug absorption, distribution and elimination. In: Goodman and Gilman's The pharmacological basis of therapeutics (8th edition). Goodman Gilman A, Rall TW, Nies AS, Taylor P (Eds.) Pergamon Press, New York, (1991) Pp 3-32.
27. MORKUNAS AR, MILLER MB: Anticonvulsant hypersensitivity syndrome. Crit. Care Clin. (1997) 13(4):727-739.
28. BROWN TS, APPEL JE, KASTELER JS, CALLEN JP: Hypersensitivity reaction in a child due to lamotrigine. Pediatr. Dermatol. (1999) 16(1):46-49.
29. MAGGS JL, NAISBITT DJ, TETTEY JN, PIRMOHAMED M, PARK BK: Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem. Res. Toxicol. (2000) 13(11):1075-1081.
30. PLANTIN P, CARTIER H, LE BIHAN G, CLOUARD P, LELLOUCHA F, LEROY JP: Syndrome d'hyeprsensibility medicamenteuse au cours, d'un traitement par acide valproique. Presse Med. (1985) 24(34):1624.
31. NEUMANN MG, MALKIEWICZ IM, PHILLIPS EJ et al.: Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Ther. Drug Monit. (2002) 24(6):728-736.
32. BELLER TC, BOYCE JA: Prolonged anticonvulsant hypersensitivity syndrome related to lamotrigine in a patient with human immunodeficiency virus. Allerg. Asthma Proc. (2002) 23(6):415-419.
33. LEEDER JS, RILEY RJ, COOK VA, SPIELBERG SP: Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J. Pharmacol. Exp. Ther. (1992) 263(1):360-367.
34. PIRMOHAMED M, KITTERINGHAM NR, BRECKENRIDGE AM, PARK BK: Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity. Br. J. Clin. Pharmacol. (1992) 33(2):183-186.
35. RZANY B, CORREIA O, KELLY JP, NALDI L, AUQUIER A, STERN R: Risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis during first weeks of anti-epileptic therapy: a case control study. Study group of the International Case control study on Severe Cutaneous Adverse Reactions. Lancet (1999) 353(9171):2190-2194.
36. HARUDA F: Phenytoin hypersensitivity: 38 cases. Neurology (1979) 29(11):1480-1485.
37. SCHLIENGER RG, SHEAR NH: Antiepileptic drug hypersensitivity syndrome. Epilepsia (1998) 39(Supp 7):S3-S7.
38. BABA M, KARAKAS M, AKSUNGUR VL, HOMAN S, YUCEL A, ACAR MA, MEMISOGLU HR: The anticonvulsant hypersensitivity syndrome. JEADV (2003) 17(4):399-401.
39. CIERNIK IF, THIEL M, WIDMER U: Anterior uveitis and the anticonvulsant hypersensitivity syndrome. Arch. Intern. Med. (1998) 158(2):192.
40. SCHREIBER M, McGREGOR J: Pseudolymphoma syndrome. Arch. Derm. (1968) 97(3):297-300.
41. D'INCAN N, SOUTEYRAND P, BIGNON Y, FONCK Y, ROGER H: Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome. Arch. Dermatol. (1992) 128(10):1371-1374.
42. YATES P, STOCKDILL G, MCINTYRE M: Hypersensitivity to carbamazepine presenting as pseudolymphoma. J. Clin. Pathol. (1986) 39(11):1224-1228.
43. SHUTTLEWORTH D, GRAHAM-BROWN R, WILLIAMS A, CAMPBELL AC, SEWELL H: Pseudolymphoma associated with carbamazepine. Clin. Exp. Dermatol. (1984) 9(4):421-423.
44. MOSTELLA J, PIERONI R, JOSE R, FINCH CK: Anticonvulsant hypersensitivity syndrome: Treatment with corticosteriods and intravenous immunoglobulin. Southern Med. J. (2004) 97(3):319-321.
45. BROWN CE, SMITH GD, CONIGLIONE T: Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin. J. Fam. Pract. (1997) 45(5):434-437.
46. GRIEBEL ML: Acute management of hypersensitivity reactions and seizures. Epilepsia (1998) 39(Supp 7):S17-S21.
47. TOUSSAINT S, KAMINO H. Non-infectious erythematous papular and squamous diseases of the skin. In: Lever's Histopathology of Skin (8th edition), Elder D (Ed.), Lippincott-Raven, Philadelphia (1997) Pp151-184.
48. ACKERMAN BA. Histologic diagnosis of inflammatory skin diseases, Philadephia Lea and Febiger (1978) Pp581-639.
49. BESSMERTNY O, PHAM T: Anitepileptic hypersensitivity syndrome. Curr. Allergy Asthma Rep. (2002) 2(1):34-49.
50. PIRMOHAMED M, GRAHAM A, ROBERTS P et al.: Carbamazepine hypersensitivity: Assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. Br. J. Clin. Pharmacol. (1991) 32(6):741-749.
51. NEUMAN MG, MALKIEWICZ IM, SHEAR NH: A novel LTA to assess drug hypersensitivity syndromes. Clin. Biochem. (2000) 33(7):517-524.
52. JONES M, FERNANDEZ-HERRERA J, DORADO J, SOLS M, RUIZ M, GARCIA-DIEZ A: Epicutaneous test in carbamazepine cutaneous reactions. Dermatology (1994) 188(1):18-20.
53. ALANKO K: Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis (1993) 29(5):254-257.
54. BERTZ RJ, HOWRIE DL: Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann. Pharmacother. (1993) 27(3):298-301.
55. HAMER HM, MORRIS HH: Successful treatment with gabapentine in the presence of hypersensitivity syndrome to phenytoin and carbamazepine: a report of three cases. Seizure (1999) 8(3):190-192.
56. SCHEUERMAN O, NOFECH-MOSES Y, RACHMEL A, ASHKENAZI S: Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immunoglobulin. Pediatrics (2001) 107(1):E14.
57. BAVDEKAR SB, MURANJAN MN, GOGTAY NJ, KANTHARIA V, KSHIRSAGAR NA: Anticonvulsant hypersensitivity syndrome: Lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann. Pharmacother. (2004) 38(10):1648-1650.
58. MANI KS, RANGAN G, SRINIVAS HV, SRINDHARAN VS, SUBBAKRISHNA DK: Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet (2001) 357(9265):1316-1320.
59. DYER O: New 20 year patents threaten to end AIDS drugs for developing countries. Br. Med. J. (2004) 329(7478):1308.